Alembic Pharma obtains final approval from Usfda for generic Doryx tablets | Latest News Headlines

Alembic Pharma is the center of attention as the company has obtained final approval from the United States Food & Drug Administration (USFDA) for doxycycline hyclate delayed-release tablets. It is a drug which is used to treat bacteria resistant to drugs. Their market size is quite small, so it’s around $ 10 million in terms of total market size, but nonetheless, it adds to their kitty in terms of approvals when it comes to US markets.

Watch CNBC-TV18’s Ekta Batra companion video for more details.

First publication: 04 Jan 2022, 13:24 STI